The mechanism of action for the anti-leukemia effect of apatinib on AML was associated with downregulating the level of VEGFR phosphorylation (p-VEGFR) and its downstream pro-survival pathways [22]. The gene discussed is KDR; the disease is acute myeloid leukemia.